Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Petrus Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (37)
Cancellation by sponsor (36)
Cancellation or suspension (2)
Listed medicine compliance report (1)

Date

2026 (8)
2025 (7)
2024 (6)
2023 (9)
2022 (3)
2021 (3)
2020 (7)
2019 (6)
2018 (5)
2017 (1)
2015 (2)
2014 (1)
2013 (1)
2012 (1)
2011 (1)
2009 (1)
2008 (1)
2007 (2)
2006 (1)
2001 (1)
1993 (1)
1992 (5)
1991 (3)

Search

Sponsor content

76 result(s) found, displaying 21 to 30

Vita-D VITAMIN D SUPPLEMENT (Petrus Pharmaceuticals Pty Ltd)

31 May 2024

Listed medicine compliance report

Medicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)
Pyridox VITAMIN B6 SUPPLEMENT (383717)

9 February 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Pyridox VITAMIN B6 SUPPLEMENT.
Mag-Sup High Absorption Magnesium Supplement Berry Flavoured Powder (382671)

17 January 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Mag-Sup High Absorption Magnesium Supplement Berry Flavoured Powder.
SENNA-GEN (382272)

10 January 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SENNA-GEN.
Mag-Sup PBS. MAGNESIUM SUPPLEMENT HIGH ABSORPTION Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd
Cal-600 CALCIUM SUPPLEMENT Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd
Senna-Gen Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd
Foltabs FOLIC ACID SUPPLEMENT Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd
Cal-600 CALCIUM SUPPLEMENT Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd
Cal-600+D CALCIUM & VITAMIN D SUPPLEMENT Cancelled under Section 30(1)(c) of the Act

23 June 2023

Cancellation by sponsor

Requested by Petrus Pharmaceuticals Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.